Evidence map›Paper›PMID 33094833›Full record

ArticleThe Laryngoscope2021

SARS-CoV-2 Presence in the Saliva, Tears, and Cerumen of COVID-19 Patients.

Fatih M Hanege, Esra Kocoglu, Mahmut T Kalcioglu, Serdal Celik, Yasemin Cag, Fehim Esen, Eray Bayindir, Sadrettin Pence, Emine Alp Mese, Canan Agalar

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in The Laryngoscope, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 36 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Comparing SARS-CoV-2 Viral Load in Human Saliva to Oropharyngeal Swabs, Nasopharyngeal Swabs, and Sputum: A Systematic Review and Meta-Analysis.The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2023
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Measuring the Possibility of Middle Ear Discharge for COVID-19 Test Material.Interdisciplinary perspectives on infectious diseases · 2022
    Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Ocular Involvement of SARS-CoV-2 in a Polish Cohort of COVID-19-Positive Patients.International journal of environmental research and public health · 2021
    Article
  17. Article
  18. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Fatih M HanegeDepartment of Otorhinolaryngology and Head and Neck Surgery, Istanbul Medeniyet University Faculty of Medicine, Istanbul, Turkey.
Esra KocogluDepartment of Medical Microbiology, Istanbul Medeniyet University Faculty of Medicine, Istanbul, Turkey.
Mahmut T KalciogluDepartment of Otorhinolaryngology and Head and Neck Surgery, Istanbul Medeniyet University Faculty of Medicine, Istanbul, Turkey.ORCID 0000-0002-6803-5467
Serdal CelikDepartment of Otorhinolaryngology and Head and Neck Surgery, Istanbul Medeniyet University Faculty of Medicine, Istanbul, Turkey.
Yasemin CagDepartment of Infectious Diseases and Clinical Microbiology, Istanbul Medeniyet University Faculty of Medicine, Istanbul, Turkey.
Fehim EsenDepartment of Ophthalmology, Istanbul Medeniyet University Faculty of Medicine, Istanbul, Turkey.
Eray BayindirDepartment of Otorhinolaryngology and Head and Neck Surgery, Istanbul Medeniyet University Faculty of Medicine, Istanbul, Turkey.
Sadrettin PenceDepartment of Physiology, Istanbul Medeniyet University Faculty of Medicine, Istanbul, Turkey.
Emine Alp MeseDepartment of Infectious Diseases and Clinical Microbiology, Republic of Turkey Ministry of Health, Ankara, Turkey.
Canan AgalarDepartment of Infectious Diseases and Clinical Microbiology, Saglik Bilimleri University Fatih Sultan Mehmet Training and Research Hospital, Istanbul, Turkey.
Istanbul Medeniyet University · TRGülhane Askerî Tıp Akademisi · TRMinistry of Health · TRSağlık Bilimleri Üniversitesi · TR

Funding

Infectious Diseases and Clinical Microbiology Specialty Society of Turkey (Turkiye EKMUD).
6 · The paper itself

Abstract

objectives/hypothesisThe emergence of a new coronavirus strain (SARS-CoV-2) in December 2019 from China led to a global pandemic. The lack of herd immunity against this virus and the possibility of viral spread from asymptomatic individuals is still a major challenge for the prevention of viral transmission. The aim of this study was to evaluate the presence of the virus in different bodily secretions as a potential source of viral spread among patients infected with SARS-CoV-2. STUDY

designCross Sectional Study.

methodsThe study included 38 COVID-19 patients with a positive real-time polymerase chain reaction (RT-PCR) test result for SARS-CoV-2, obtained from the combined nasopharyngeal-oropharyngeal swab samples. Saliva, tear, and cerumen samples were taken from the patients within 72 hours of the first RT-PCR test. SARS-CoV-2 N1 and N2 gene regions were studied with single-step RT-PCR in all samples.

resultsAmong the studied samples, the highest positivity rate was in saliva (76.3%) followed by tears (55.3%) and cerumen (39.5%). Viral load in saliva was also significantly higher compared to tears and cerumen (P < .001), while there was no significant difference between tears and cerumen. Higher viral load in combined nasopharyngeal-oropharyngeal swab samples was associated with higher viral load in tears, but not in saliva or cerumen. Half of the saliva, tear, and cerumen samples obtained from asymptomatic patients contained SARS-CoV-2 genome.

conclusionsThe virus was detected in the saliva, tears, and cerumen samples of both symptomatic and asymptomatic patients. The potential role of these bodily fluids on viral spread needs to be studied. LEVEL OF EVIDENCE: 4 Laryngoscope, 131:E1677-E1682, 2021.

Indexed as

AdultAgedAngiotensin-Converting Enzyme 2CerumenChinaCOVID-19COVID-19 TestingCross-Sectional StudiesFemaleHumansMaleMiddle AgedNasopharynxOropharynxReal-Time Polymerase Chain ReactionSalivaAngiotensin-Converting Enzyme 2cerumenCOVID-19salivaSARS-CoV-2tear

Identifiers

PMID33094833
OpenAlexW3094440392

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.